External broker reports(aggregated public sources), Axis Direct

Axis Direct

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>Robust Operational Performance: The company delivered a strong performance in Q4FY26 and FY26, supported by healthy demand traction, improved realisations, and sustained margin expansion.</li><li>Operational efficiencies, favourable product mix, and higher contribution from value-added segments aided profitability during the quarter.</li><li>Pharma Segment Emerging as a Key Growth Driver: The Pharma packaging business continued to witness strong momentum, with volumes surging 209% in FY26, reflecting rapid scale-up and deeper penetration in the pharmaceutical packaging market. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Robust Operational Performance: The company delivered a strong performance in Q4FY26 and FY26, supported by healthy demand traction, improved realisations, and sustained margin expansion.Operational efficiencies, favourable product mix, and higher contribution from value-added segments aided profitability during the quarter.Pharma Segment Emerging as a Key Growth Driver: The Pharma packaging business continued to witness strong momentum, with volumes surging 209% in FY26, reflecting rapid scale-up and deeper penetration in the pharmaceutical packaging market. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Mold-Tek Packaging Ltd - Beat On All Fronts; Maintain BUY

<ul><li>Pharma Division – Sustained Momentum: The pharma packaging segment continued to deliver robust growth, with revenue increasing 45% QoQ to Rs 10.8 Cr, albeit on a low base (Rs 7.4 Cr in Q1FY26).</li><li>Management highlighted pharma packaging as a key structural growth driver, supported by new client additions, innovative product offerings, and increasing capacity utilization (&gt;50%).</li><li>The company reiterated its FY26 revenue target of Rs 35 Cr, with a peak potential of Rs 55–60 Cr at current capacity, indicating a meaningful contribution to margin expansion over the medium term.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Pharma Division – Sustained Momentum: The pharma packaging segment continued to deliver robust growth, with revenue increasing 45% QoQ to Rs 10.8 Cr, albeit on a low base (Rs 7.4 Cr in Q1FY26).Management highlighted pharma packaging as a key structural growth driver, supported by new client additions, innovative product offerings, and increasing capacity utilization (&gt;50%).The company reiterated its FY26 revenue target of Rs 35 Cr, with a peak potential of Rs 55–60 Cr at current capacity, indicating a meaningful contribution to margin expansion over the medium term.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Mold-Tek Packaging - Performance In Line with Expectations; Maintain BUY

<ul><li>Robust Performance Across Key Segments: The company reported strong volume growth of 15% YoY and 16.9% QoQ, indicating sustained operational momentum across all major business verticals.</li><li>This performance was underpinned by an optimised product mix and improved capacity utilisation.</li><li>Notably, the Paint Packs segment was a major growth contributor, registering a robust 28.3% QoQ increase in volumes.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Robust Performance Across Key Segments: The company reported strong volume growth of 15% YoY and 16.9% QoQ, indicating sustained operational momentum across all major business verticals.This performance was underpinned by an optimised product mix and improved capacity utilisation.Notably, the Paint Packs segment was a major growth contributor, registering a robust 28.3% QoQ increase in volumes.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Mold-Tek Packaging - Beat On All Fronts; Maintain BUY

Thematic (Sector/Industry)

<ul><li>As we enter 2026, the Indian equity market stands at a critical inflection point — transitioning from a phase dominated by domestic liquidity to one where earnings delivery, policy alignment, and macro stability will be the primary drivers of returns.</li><li>Indian equities saw divergent performance in 2025, with the Nifty 50 hitting a record high of 26,326 on 1 st December and delivering a 10.2% annual return.</li><li>Broader markets lagged, as the Nifty 500 rose 6.4% and the Nifty smallcap 250 fell 6.4% as of 1 st Dec, 2025. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

As we enter 2026, the Indian equity market stands at a critical inflection point — transitioning from a phase dominated by domestic liquidity to one where earnings delivery, policy alignment, and macro stability will be the primary drivers of returns.Indian equities saw divergent performance in 2025, with the Nifty 50 hitting a record high of 26,326 on 1 st December and delivering a 10.2% annual return.Broader markets lagged, as the Nifty 500 rose 6.4% and the Nifty smallcap 250 fell 6.4% as of 1 st Dec, 2025. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

New Year Picks 2026: Capturing India’s Next Growth Phase

<ul><li>The Q1FY26 earnings season was marked with interesting events such as 1) Geopolitical tension, 2) Volatility in Crude Prices, 3) Interest rate cuts, 4) Unseasonal Rainfall, 5) Supply chain disruptions, and 6) Improving liquidity.</li><li>These developments indicate Q1FY26 earnings season is expected to exhibit a mix trend, similar to the patterns observed in previous quarters.</li><li>Some breather is expected in Q1FY26 on account of sequential improvement in some of the pockets of high-frequency indicators. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

The Q1FY26 earnings season was marked with interesting events such as 1) Geopolitical tension, 2) Volatility in Crude Prices, 3) Interest rate cuts, 4) Unseasonal Rainfall, 5) Supply chain disruptions, and 6) Improving liquidity.These developments indicate Q1FY26 earnings season is expected to exhibit a mix trend, similar to the patterns observed in previous quarters.Some breather is expected in Q1FY26 on account of sequential improvement in some of the pockets of high-frequency indicators. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

India

Mold-Tek Packaging Ltd. manufactures plastic packaging products.  The Company manufactures bottles for pharmaceuticals and cosmetics; child-resistant caps; flip-top tablet packs; blow-molded shampoo and medicine packs; and injection-molded pails for lubricants, chemicals, paint, ink, adhesives and bulk drugs.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Mold Tek Packaging (MTEP IN)

Mold-Tek Packaging Ltd - Beat On All Fronts; Maintain BUY

The company delivered a strong performance in Q4FY26 and FY26, supported by healthy demand traction, improved realisations, and sustained margin...

Axis Direct

Mold-Tek Packaging - Performance In Line with Expectations; Maintain BUY

The pharma packaging segment continued to deliver robust growth, with revenue increasing 45% QoQ to Rs 10.8 Cr, albeit on a low base (Rs 7.4 Cr in...

Axis Direct

Mold-Tek Packaging - Beat On All Fronts; Maintain BUY

The company reported strong volume growth of 15% YoY and 16.9% QoQ, indicating sustained operational momentum across all major business verticals.

Axis Direct

New Year Picks 2026: Capturing India’s Next Growth Phase

As we enter 2026, the Indian equity market stands at a critical inflection point — transitioning from a phase dominated by domestic liquidity to...

Axis Direct

Q1FY26 - Consolidated Earnings Preview

Some breather is expected in Q1FY26 on account of sequential improvement in some of the pockets of high-frequency indicators.

Axis Direct

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)